124 related articles for article (PubMed ID: 15114428)
21. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Clark DW; Strandell J
Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
[TBL] [Abstract][Full Text] [Related]
22. Admission creatine phosphokinase in acute poisoning: is it a predictive factor for the treatment outcome?
Eizadi-Mood N; Sabzghabaee AM; Gheshlaghi F; Mehrzad F; Fallah Z
J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S67-70. PubMed ID: 22768464
[TBL] [Abstract][Full Text] [Related]
23. Perioperative chronic use of statins and the risk of muscle complaints in patients undergoing knee and hip endoprosthesis surgery.
Laisalmi-Kokki M; Tolonen K; Miettinen H; Kokki H
J Clin Anesth; 2010 Mar; 22(2):81-7. PubMed ID: 20304347
[TBL] [Abstract][Full Text] [Related]
24. Incidence of adverse cutaneous drug reactions in 22,866 Chinese inpatients: a prospective study.
Tian XY; Liu B; Shi H; Zhao ZR; Zhou XP; Zhang T; Sun QN; Zuo YG
Arch Dermatol Res; 2015 Nov; 307(9):829-34. PubMed ID: 26246330
[TBL] [Abstract][Full Text] [Related]
25. [Muscular damage during isotretinoin treatment].
Heudes AM; Laroche L
Ann Dermatol Venereol; 1998 Feb; 125(2):94-7. PubMed ID: 9747221
[TBL] [Abstract][Full Text] [Related]
26. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
[TBL] [Abstract][Full Text] [Related]
27. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
[TBL] [Abstract][Full Text] [Related]
28. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study.
Ahmed B; Nanji K; Mujeeb R; Patel MJ
PLoS One; 2014; 9(11):e112133. PubMed ID: 25402452
[TBL] [Abstract][Full Text] [Related]
29. Frequency of adverse drug reactions in children: a prospective study.
Jonville-Béra AP; Giraudeau B; Blanc P; Beau-Salinas F; Autret-Leca E
Br J Clin Pharmacol; 2002 Feb; 53(2):207-10. PubMed ID: 11851647
[TBL] [Abstract][Full Text] [Related]
30. An insight into statin use and its association with muscular side effects in clinical practice.
Farcas A; Bucsa C; Leucuta D; Mogosan C; Bojita M; Dumitrascu D
Rom J Intern Med; 2015; 53(2):153-60. PubMed ID: 26402985
[TBL] [Abstract][Full Text] [Related]
31. Statin-associated myopathy.
Thompson PD; Clarkson P; Karas RH
JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
[TBL] [Abstract][Full Text] [Related]
32. [Atypical muscular syndrome with myolysis during long-term treatment with fibrates].
Chauvin M; Zupan M; Brechenmacher C
Arch Mal Coeur Vaiss; 1988 Jul; 81(7):921-3. PubMed ID: 3142389
[TBL] [Abstract][Full Text] [Related]
33. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.
Nichols GA; Koro CE
Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557
[TBL] [Abstract][Full Text] [Related]
34. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
[TBL] [Abstract][Full Text] [Related]
35. Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis.
Andrade SE; Graham DJ; Staffa JA; Schech SD; Shatin D; La Grenade L; Goodman MJ; Platt R; Gurwitz JH; Chan KA
J Clin Epidemiol; 2005 Feb; 58(2):171-4. PubMed ID: 15680751
[TBL] [Abstract][Full Text] [Related]
36. Adverse drug reactions in elderly patients following discharge from an internal medicine clinic.
Marusic S; Sicaja M; Obreli Neto PR; Franic M; Marinovic I; Bacic-Vrca V
Int J Clin Pharmacol Ther; 2014 Oct; 52(10):906-13. PubMed ID: 25066228
[TBL] [Abstract][Full Text] [Related]
37. Statin safety: an assessment using an administrative claims database.
Cziraky MJ; Willey VJ; McKenney JM; Kamat SA; Fisher MD; Guyton JR; Jacobson TA; Davidson MH
Am J Cardiol; 2006 Apr; 97(8A):61C-68C. PubMed ID: 16581331
[TBL] [Abstract][Full Text] [Related]
38. Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.
Pedrós C; Formiga F; Corbella X; Arnau JM
Eur J Clin Pharmacol; 2016 Feb; 72(2):219-26. PubMed ID: 26546335
[TBL] [Abstract][Full Text] [Related]
39. Creatine kinase: a review of its use in the diagnosis of muscle disease.
Gasper MC; Gilchrist JM
Med Health R I; 2005 Nov; 88(11):398, 400-4. PubMed ID: 16363394
[No Abstract] [Full Text] [Related]
40. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
